Breast cancer treatment involves targeting key genes involved in cell proliferation, differentiation, and apoptosis, such as PIK3CA, CCND1, HER2, STAT3, WNT1, and KRAS [47,48,49,50,51,52]. This evidence concerns the gene ERBB2 and breast carcinoma.